Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AI and Machine Learning
Biotech
Alphabet's AI biotech Isomorphic Labs bags $2.1B series B
If any proof was needed that big money is still available for AI drug development, look no further than the 10-figure series B hauled in by Isomorphic
James Waldron
May 12, 2026 11:45am
Novo salvages happy ending for scrapped Parkinson’s therapy
May 11, 2026 8:30am
Amgen-backed quantum computing firm plans IPO
May 10, 2026 8:25am
From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI
May 7, 2026 9:10am
Recursion's new CEO is bringing the AI outfit back to earth
May 6, 2026 6:30am
Fierce Pharma
Sanofi invests $294M to scale Toronto AI hub
May 5, 2026 9:21am
